Atropos Health, the pioneer in translating real-world clinical data into personalized real-world evidence (RWE) for clinical ...
Clinical trial quality starts with culture. Learn how one company’s ethical lapses led to bankruptcy—and how the ASPIRE ...
IDEAYA Biosciences and Servier have reported positive top line results from the Phase II/III registration trial, OptimUM-02, ...
The US Food and Drug Administration (FDA) has reminded more than 2,200 sponsors and researchers to publicly publish their ...
Trastuzumab pamirtecan, an investigational HER2-targeted antibody-drug conjugate, met the primary efficacy endpoint in a Phase 2 cohort of ...
This issue aims to showcase how machine learning (ML) and Artificial Intelligence (AI) approaches can be used with real world data (RWD) sources to generate ...
Avalyn Pharma's IPO aims to fund inhaled IPF therapies as AP01 shows positive Phase II results. Read the full analysis here.
Biomedical data analysis has evolved rapidly from convolutional neural network-based systems toward transformer architectures and large-scale foundation ...
Many researchers prefer the “live” data that comes from real-world results while still acknowledging potential shortcomings.
As clinical trials grow more complex, so does the volume of data that requires medical and operational review. Phase III trials now generate an average of 3.6 million data points—three times the ...
Placebo and “knowcebo” effects are a problem. But they can also help people feel better. This week I want to look at where we are with psychedelics, the mind-altering substances that have somehow made ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results